Day: June 17, 2021

NEW YORK, New York and SHANGHAI, June 17, 2021 (GLOBE NEWSWIRE) — Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, OTC: XYNO), a clinical stage US-China oncology drug development company, announced that it closed a short form merger with and into Xu-Nuo Pharma, Inc., a Delaware corporation and holder of approximately 98% of the outstanding common shares in Xynomic (“Parent”) pursuant to an agreement and plan of merger (the “Merger Agreement”) with Parent. Pursuant to the Merger Agreement and subject to the terms and conditions thereof, Xynomic merged with and into Parent, with Parent continuing as the surviving corporation of the merger (the “Merger”) at about 8:30 a.m. Eastern Time on June 17, 2021, or the effective time of the Merger. The Merger effects the going private with respect to Xynomic under Delaware General Corporation...

Drew MarkhamMicroVision General CounselREDMOND, Wash., June 17, 2021 (GLOBE NEWSWIRE) — MicroVision, Inc. (NASDAQ: MVIS), a leader in MEMS based solid state automotive lidar and micro-display technology for augmented reality, today announced the appointment of Drew Markham as General Counsel, reporting to Chief Executive Officer Sumit Sharma. “I am pleased to welcome Drew to MicroVision,” said Sumit Sharma, Chief Executive Officer at MicroVision. “Drew’s breadth of legal experience, in particular her transactional and governance work, will be an asset to the company as we focus on engaging with potential customers and partners, demonstrating key features of our long-range lidar sensor, as well as with parties interested in strategic opportunities.” Markham has more than 20 years of experience advising publicly...

South Plainfield, NJ and Denver, CO campuses chosen as 2 of top 60 schools nationwide Parsippany, NJ, June 17, 2021 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), marking 75 years in 2021 as a national leader in specialized technical training, has announced that two of its Lincoln Tech campuses have been named top schools by Daimler Trucks North America (DTNA). The South Plainfield, NJ and Denver, CO campuses were ranked sixth and sixteenth, respectively.   DTNA’s Get Ahead partnership program gives students training for Diesel Technology careers the opportunity to build advanced skills with manufacturer-specific technology. By supporting students in their pursuit of these careers, the program helps ensure Daimler’s facilities have enough qualified candidates to fill open positions and keep their operations...

OMAHA, Neb., June 17, 2021 (GLOBE NEWSWIRE) — On June 17, 2021, America First Multifamily Investors, L.P. (NASDAQ: ATAX) (the “Partnership” or “ATAX”) announced that the Board of Managers of Greystone AF Manager LLC (“Greystone Manager”) declared a quarterly cash distribution to the Partnership’s Beneficial Unit Certificate (“BUC”) holders of $0.11 per BUC. The distribution, payable on July 30, 2021 to BUC holders of record as of the close of trading on June 30, 2021, marks a 22 percent increase from the previous quarterly distribution of $0.09 per BUC, which was declared in the first quarter of 2021. The BUCs will trade ex-distribution as of June 29, 2021. Greystone Manager is the general partner of America First Capital Associates Limited Partnership Two, the Partnership’s general partner. Distributions to the Partnership’s BUC...

TORONTO, June 17, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into an agreement with the University of Health Sciences Antigua (“UHSA”) to collaborate on utilizing Revive’s novel psychedelic-assisted therapies and pioneering the clinical research and development of psychedelics in Antigua and Barbuda. “We are excited to partner with UHSA as the relationship complements and accelerates our research and commercial goals with psychedelics and advances our patented drug delivery technology to deliver psychedelics in an oral thin film patch and topical forms in human clinical studies to support regulatory...

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) — Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced that it will present data at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2021, being held virtually from June 23-26, 2021. Data to be presented includes results from the Company’s Phase 1 trial of MET642, a farnesoid X receptor (FXR) agonist being developed for the treatment of non-alcoholic steatohepatitis (NASH), as well as one oral presentation and one poster focused on preclinical studies examining FXR agonists in rare adult and pediatric cholestatic liver diseases. The full list of Metacrine and partner presentations are listed below: Poster PO-393: MET642,...

Online Event Scheduled for Monday, June 21, 2021, at 2:00 p.m., ET Event to Spotlight Seclidemstat and Feature Experts in the Fields of Epigenetics, Sarcomas, and Hematological Cancers HOUSTON, June 17, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced that it will host a virtual key opinion leader (KOL) and investor event focused on the scientific rationale and clinical development of seclidemstat, the Company’s lead drug candidate. Seclidemstat is a novel, oral, reversible inhibitor of lysine-specific histone demethylase 1 (LSD1), an enzyme that has been shown to play a key role in the development and progression of several cancers. The online...